Page last updated: 2024-12-04

beta-lysine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

beta-lysine: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID392
CHEMBL ID5222185
SCHEMBL ID159650
MeSH IDM0180320

Synonyms (19)

Synonym
hexanoic acid, 3,6-diamino-
3,6-diaminohexanoic acid
57pay56q9j ,
unii-57pay56q9j
4299-56-3
beta-lysine
AKOS006341734
SCHEMBL159650
isolysine
3,6-diamino-hexanoic acid
Q2930104
DTXSID20962838
A930127
EN300-719134
.beta.-lysine
(+-)-3,6-diamino-hexanoic acid
isolysin
3,6-diaminohexanoicacid
CHEMBL5222185

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Its antibacterial activity is superior to that of vancomycin in MRSA mouse and human ex vivo skin infection models, with no acute in vivo toxicity in repeated dosing in mice at above therapeutic levels."( Enantiomeric glycosylated cationic block co-beta-peptides eradicate Staphylococcus aureus biofilms and antibiotic-tolerant persisters.
Bazan, GC; Chan-Park, MB; Chi, YR; De, PP; Du, Y; Duan, H; Hammond, PT; Jothy, SL; Keogh, D; Kreiswirth, BN; Liu, XW; Liu, Y; Marimuthu, K; Mediavilla, JR; Mu, Y; Ng, OT; Pethe, K; Raju, C; Reghu, S; Ren, J; Ruan, L; Si, Z; Tam, KC; Turvey, ME; Zhang, K; Zhu, Y, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (37)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (35.14)18.7374
1990's7 (18.92)18.2507
2000's7 (18.92)29.6817
2010's6 (16.22)24.3611
2020's4 (10.81)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.17

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.17 (24.57)
Research Supply Index3.64 (2.92)
Research Growth Index4.61 (4.65)
Search Engine Demand Index49.59 (26.88)
Search Engine Supply Index2.27 (0.95)

This Compound (34.17)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (5.41%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other35 (94.59%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]